Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys

BACKGROUND: In the first 2 years after a nationwide mass vaccination campaign of 1–29-year-olds with a meningococcal serogroup A conjugate vaccine (MenAfriVac) in Burkina Faso, carriage and disease due to serogroup A Neisseria meningitidis were nearly eliminated. We aimed to assess the long-term eff...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Infect Dis
Main Authors: Mbaeyi, Sarah, Sampo, Emmanuel, Dinanibè, Kambiré, Yaméogo, Issaka, Congo-Ouédraogo, Malika, Tamboura, Mamadou, Sawadogo, Guetawendé, Ouattara, Kalifa, Sanou, Mahamadou, Kiemtoré, Tanga, Dioma, Gerard, Sanon, Barnabé, Somlaré, Hermann, Kyetega, Augustin, Ba, Absatou Ky, Aké, Flavien, Tarbangdo, Félix, Aboua, Frederic Acho, Donnou, Yvette, Kamaté, Idrissa, Patel, Jaymin C, Schmink, Susanna, Spiller, Michael W, Topaz, Nadav, Novak, Ryan, Wang, Xin, Bicaba, Brice, Sangaré, Lassana, Ouédraogo-Traoré, Rasmata, Kristiansen, Paul A
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science ;, The Lancet Pub. Group 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689286/
https://ncbi.nlm.nih.gov/pubmed/32653071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(20)30239-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados